Market Tracker

09/25 9:11am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.94
Delayed Data
As of Sep 22
 -0.0001 / -0.00%
Today’s Change
1.83
Today|||52-Week Range
7.15
+51.55%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.94
Today’s open2.93
Day’s range2.90 - 2.99
Volume60,338
Average volume (3 months)188,825
Market cap$32.7M
Dividend yield--
Data as of 09/22/2017

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.10+1.73%
PPHMPPeregrine Pharmaceut...-0.03-0.15%
TCONTRACON Pharmaceutica...+0.02+0.70%
AMPEAmpio Pharmaceutical...0.000.00%
Data as of 7:59pm ET, 09/22/2017

Financials

Next reporting dateNovember 10, 2017
EPS forecast (this quarter)-$4.10
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts